AEON
AEON Biopharma·AMEX
--
--(--)
--
--(--)
5.33 / 10
Netural
Fund-flow data reveal a robust 7.18/10 score, with positive trends in block, small, and extra-large transactions, despite neutral-medium flows. This indicates institutional accumulation and supportive sentiment. Coupled with a unanimous Strong Buy analyst view (100% from Aegis Capital), the funding backdrop is constructive, offsetting some technical weaknesses.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-08
InstitutionAegis Capital
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of AEON?
- AEON holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.33/10 (Netural).
